BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will moderate the panel "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
News | 03. 21. 2013
Art Pappas will moderate a panel titled, "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
